LUMIRA VENTURES
LUMIRA VENTURES is a Pre-seed, Seed, Series A, Series B and Series C+ fund in the US writing $5M–$50M checks into Healthcare, biotechnology and medical-devices.
- Stages
- Pre-seed, Seed, Series A, Series B, Series C+
- Sectors
- Healthcare, biotechnology, medical-devices
- Check size
- $5M–$50M
- Invests in
- US-wide
- Actively investing
- Yes
- Founded
- 1989
- Assets under management
- $255M
- Website
- lumiraventures.com
Thesis
Lumira Ventures is a North American healthcare venture capital firm focused on investments in the life sciences sector, specifically therapeutic products and medical devices. They target a broad range of therapeutic areas with high unmet clinical needs, investing from pre-seed to growth equity stages, including Seed, Series A, Series B, and Series C. Lumira Ventures seeks to partner with mission-driven entrepreneurs dedicated to developing impactful products for patients, enhancing patient outcomes, and creating inclusive healthcare solutions. They focus on building biotechnology and medical technology companies across North America, with an emphasis on high-impact innovation and underserved markets beyond traditional venture hubs. Their latest Fund IV closed at $220 million, and they are targeting $200 million for Lumira Ventures V, LP.
Common questions
Does LUMIRA VENTURES invest at the Pre-seed stage?
Yes. LUMIRA VENTURES lists Pre-seed, Seed, Series A, Series B and Series C+ among the stages it invests in.
What check size does LUMIRA VENTURES write?
LUMIRA VENTURES writes $5M–$50M checks.
Where does LUMIRA VENTURES invest?
LUMIRA VENTURES invests in the US.